ABSTRACT -The nuclear receptor superfamily consists of ligand-dependent transcription factors. Among them, constitutive androstane receptor (CAR) plays a key role in the detoxification of xenobiotics, inducing various drug-metabolizing enzymes including human CYP2B6 and its homologues of other species. AMP-activated protein kinase (AMPK) acts as an important energy sensor, being activated by an increased AMP/ATP ratio. CAR is activated by phenobarbital (PB) treatment. It has been recently reported that AMPK is involved in PB-mediated CYP2B induction both in vitro and in vivo. We investigated the relationship between the functions of AMPK and CAR in rat primary hepatocyte. The AMPKactivator 5-aminoimidazole-4-Carboxamide-1-β-Ribofuranoside (AICAR) unexpectedly repressed PB-induced CYP2B mRNA expression as well as AMPK-inhibitor compound C. In contrast, both the AMPK-activator metformin and the constitutive active form of AMPK enhanced PB-induced PB-responsive enhancer module-driven reporter gene expression. We demonstrated that AICAR prevented nuclear translocation of CAR in an AMPK-independent manner in rat primary hepatocytes. AICAR might be a convenient probe for studying the mechanisms of PB-induced activation, especially nuclear translocation, of CAR in rat primary hepatocytes.
INTRODUCTION
The nuclear receptor superfamily consists of liganddependent transcription factors. The nuclear receptor constitutive active/androstane receptor (CAR) plays a key role in the detoxification of xenobiotics. CAR has a DNA binding domain, a hinge region, and a ligand binding domain containing a C-terminal transactivation domain. CAR is normally retained in the cytoplasm of untreated liver cells and primary cultured hepatocytes in complexes with proteins such as cytoplasmic CAR retention protein and heat shock protein 90 Yoshinari et al., 2003) . CAR translocates to the nucleus after exposure to various ligands and activators, which are represented by phenobarbital (PB) (Kawamoto et al., 1999) . Following nuclear translocation, CAR binds to response elements in the promoter regions of its target genes, forming a heterodimer with retinoid X receptor α (Baes et al., 1994) . CAR regulates the expression of various drugmetabolizing enzymes.
Various CAR ligands elicit nuclear translocation of CAR by direct binding, while PB and PB-like compounds trigger nuclear translocation of CAR without direct binding (Moore et al., 2000) . However, the detailed mechanism behind PB-induced nuclear translocation of CAR has not yet been unveiled, although it is very important for understanding PB-induced activation and the physiological role of CAR.
It was recently reported that AMP-activated protein kinase (AMPK) plays an essential role in PBinduced CYP2B expression (Rencurel et al., 2005 (Rencurel et al., , 2006 Blättler et al., 2007) . AMPK acts as an important energy sensor and is activated by an increased AMP/ATP ratio. The activation of AMPK results in the repression of gluconeogenesis and fatty acid and cholesterol biosynthesis in the liver. PB can increase AMPK activity by phospho-5-Aminoimidazole-4-carboxamide-1-β-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner rylating the threonine residue (Thr-172) of its activation loop. PB-induced expression of CYP2B can be repressed by the AMPK inhibitor compound C or the dominant negative form of AMPK. In contrast, AMPK activators, such as 5-aminoimidazole-4-carboxamide-1-β-ribofuranoside (AICAR) and metformin, increase the expression of CYP2B mRNA in human and mouse primary hepatocytes (Rencurel et al., 2006) . Furthermore, the constitutive active form of AMPK synergistically enhances PBinduced CYP2B mRNA expression but not its basal expression. On the other hand, Shindo et al. (2007) demonstrated that AICAR activated PBREM-reporter gene expression, but did not induce endogenous CYP2B gene expression in rats or mice. Thus, the relationship between the roles played by CAR and AMPK in PB-induced expression of CYP2B genes is poorly understood.
In the present study, we will show that the AMPK-activator AICAR enhances the transactivation potential of CAR localized in the nuclear compartment via AMPKactivation, but prevents nuclear translocation of CAR in an AMPK-independent manner in rat primary hepatocytes. AICAR might be a useful probe for studying the mechanism of PB-induced activation of CAR.
MATERIALS AND METHODS

Chemicals and plasmid construction
AICAR, compound C, and U0126 were purchased from Calbiochem, San Diego, CA, USA. PB was obtained from WAKO Pure Chemicals, Osaka, Japan. Metformin was a product of MP Biomedicals, solon, OH, USA. The methods used to construct the pcDNA-rCAR, pEGFP-rCAR, and pGL3-PBREM plasmids have been described previously (Kanno et al., 2005a (Kanno et al., , 2005b . The constitutively active form of AMPK (CA-AMPK) (Barbara et al., 1998) was constructed as follows: The expression plasmid coding for the rat AMPKα2-(1-312) truncated mutant was constructed using the pCMV-3-Tag-6 vector (Stratagne, La Jolla, CA, USA), and the construction of the expression plasmid coding for the AMPKα2-(T172D) mutant was carried out using the QuickChange Site-Directed Mutagenesis Kit (Stratagene) and specific primers.
Cell culture
The hepatocytes were isolated from the livers of 7-week-old male Wistar rats (Clea Japan Inc., Tokyo, Japan) using the collagenase perfusion method. After enumeration of the cells by trypan blue dye exclusion, the hepatocytes were cultured in WE-medium supplemented with 10% fetal bovine serum. Four hr after plating, the medium was exchanged with WE-medium containing 10 nM dexamethasone (WAKO Pure Chemicals) and 0.05% Insulin-Transferrin-Sodium Selenite Supplement (Roche Diagnostics, Indianapolis, IN, USA).
Real time RT-PCR
Rat primary hepatocytes were seeded in 6-well collagen-coated plates. On the next day, the cells were treated with different concentrations of AICAR, 10 μM compound C, or DMSO (vehicle) for 30 min prior to the addition of 1 mM PB and were then incubated for further 6 hr. Total RNA was isolated with the SV Total RNA Isolation System (Promega, Madison, WI, USA). The RNA concentration was quantified by spectrometry at 260 nm. Reverse transcription (RT) was performed with 1 μg of total RNA and the Prime Script II 1st strand cDNA Synthesis Kit (Takara Bio, Shiga, Japan) according to the manufacturer's protocol. Real-Time PCR was performed with SYBR Green Real-time PCR Master Mix-Plus (TOYOBO, Osaka, Japan). The oligonucleotide sequences of the primers used for PCR were as follows: sense: 5'-GAGTTCTTCTCTGGGTTGCTG-3', antisense: 5'-ACT-GTGGGTCATGGAGAGCTG-3' (CYP2B1/2); sense: 5'-TCCTCCTGAGCGCAAGTACTC-3', antisense: 5'-CTGCTTGCTGATCCACATCTG-3' (β-actin).
Luciferase reporter analysis
Rat primary hepatocytes were seeded in 24-well collagen-coated plates and transfected with 500 ng of pGL3-PBREM reporter plasmid, 50 ng of rCAR-expression plasmid, 200 ng of a constitutively active AMPK (CA-AMPK)-expression plasmid (or pCMV-3Tag6), and 25 ng of the pRL plasmid using the TransFectin Transfection Reagent (Bio-Rad, Hercules, CA, USA). On the next day, the cells were treated with 1 mM PB for 24 hr. One mM AICAR and 1 mM metformin were added 30 min prior to the PB treatment, and 25 μM U0126 were added a further 30 min earlier. The cells were harvested, and the cell lysates had their luciferase activity measured according to the manufacturer's protocol (Promega).
Intracellular localization analysis
Rat primary hepatocytes were seeded in 4-well collagen-coated Chambered Coverglasses (IWAKI, Chiba, Japan). Then, the cells were transfected with pEGFPrCAR plasmids on the day of plating using the TransFectin Transfection Reagent (BIO-RAD). After overnight incubation, the cells were treated with 1mM PB for 6 hr after 30 min pretreatment with AICAR. The intracellular expression profiles of GFP-rCAR chimerical proteins were observed with a confocal laser scanning micro-scope, LSM 510 (Carl Zeiss, Jena, Germany).
RESULTS
Recently, the positive regulation of AMPK in PBdependent induction of CYP2B gene expression has been demonstrated in the mouse liver, as well as in mouse and human primary hepatocytes (Rencurel et al., 2006) . In order to confirm these findings, the effects of AMPK activators and inhibitors on CYP2B mRNA expression were evaluated using rat primary hepatocytes. The cells were treated with AICAR or compound C in the presence or absence of PB. AICAR or compound C was added 30 min before the PB or mock treatment, and the expression of mRNA for CYP2B1/2 was measured 6 hr after the PB treatment. Compound C partially suppressed the PB-dependent induction of CYP2B1/2 mRNA (Fig. 1A) .
Unexpectedly, PB-dependent induction of CYP2B1/2 mRNA was also inhibited by AICAR treatment in rat primary hepatocytes in a dose dependent manner (Figs. 1A  and B) . Additionally, the induction of CYP2B1/2 mRNA was not observed after 24 hr treatment with AICAR (Fig.  1C) .
To determine whether AICAR suppresses PB-dependent CAR activation, we measured luciferase activity using the PBREM-luciferase reporter plasmid in rat primary hepatocytes. As shown in Fig. 2A , PB-induced luciferase activity was suppressed in the presence of AICAR ( Fig. 2A) . In contrast, metformin, an AMPK activator, upregulated PB-induced luciferase activity. To investigate the involvement of AMPK activation, the constitutive active form of AMPK (CA-AMPK) was expressed in rat primary hepatocytes. The expression of CA-AMPK enhanced PB-induced luciferase activity (Fig. 2B ). These observations suggest that AICAR prevents PB-dependent CAR activation in an AMPK-independent manner. Therefore, we supposed that the AMPK-independent inhibitory effect of AICAR on PB-dependent CAR activation was dominant over AMPK-dependent activation in rat primary hepatocytes. Next, we investigated the subcellular localization of CAR in the absence or presence of AICAR. The nuclear translocation of CAR is a requisite step for PB-induced transactivation. Rat primary hepatocytes that had been transiently transfected with the expression plasmids for GFP-tagged rat CAR (GFP-rCAR) were treated with AICAR for 30 min prior to PB treatment. After 6 hr of PB treatment, the intracellular distribution of GFP-rCAR was observed by confocal microscopy (Fig. 3) . A cytoplasmic dominant distribution of fluorescence was observed in the unstimulated cells; whereas, the nuclear accumulation of GFP-rCAR was observed in PB-treated cells. However, no PB-induced nuclear accumulation of GFP-rCAR was observed when the cells were treated with AICAR in advance of the PB treatment.
DISCUSSION
In the present study, we have shown that the potent AMPK activator AICAR prevents PB-induced nuclear accumulation of CAR in rat primary hepatocytes. However, the suppression of PB-induced CYP2B1/2 mRNA expression by the AMPK inhibitor compound C suggests that AMPK is involved in positive regulation of PB-dependent induction of the CYP2B1/2 gene. Furthermore, the expression of CA-AMPK increased PBinduced PBREM-luciferase reporter activity to the same extent as metformin. These results suggest that AIC-AR prevents the nuclear accumulation of CAR in an AMPK-independent manner, masking intranuclear AMPK-dependent CAR activation, in marked contrast with the previous report that showed that AICAR induces both PBREM-luciferase reporter activity and the nuclear translocation of CAR in mice (Shindo et al., 2007) . Because the nuclear translocation could not be observed with PB in primary hepatocytes in the coexistence of AICAR. AICAR may elicit PB-induced nuclear accumulation of CAR in vivo via an indirect effect of circumferential tissues In fact, AMPK plays an essential role in the metabolic responses in the skeletal muscle (Lee-Young et al., 2009) . Alternatively, the effect of AIC-AR on CYP2B mRNA expression may be species specific. As previously reported by Rencurel et al. (2006) , AIC-AR might increase CYP2B mRNA expression in human and mouse primary hepatocytes. However, AICAR could not induce CYP2B mRNA in rat primary hepatocytes. As far as CAR is concerned, we previously reported species difference in the numbers and allocations of nuclear localization signals and nuclear export signals between human and rat CARs (Kanno et al., 2007) .
AICAR is intracellularly phosphorylated to 5-aminoimidazole-4-carboxamide-1-β-D-riboside (ZMP), and ZMP activates AMPK as an analogue of AMP (Corton et al., 1995) . However, several recent reports have sug- gested an AMPK-independent action of AICAR. AICAR depletes intracellular Pi and accumulates ZMP, thereby inducing the inhibition of cellular respiration AMPKindependently (Guigas et al., 2007) AICAR also inhibits phosphatidylcholine biosynthesis in isolated hepatocytes in an AMPK-independent manner (Jacobs et al., 2007) . The mechanisms of the AMPK-independent inhibition of the nuclear translocation of CAR mediated by AICAR remain to be elucidated.
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